Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ONXX
201
CALL
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $64.8M | 0.1% |
519,800
+453,000
| +678% | +$57.4M |
2013 Q2
1 quarter
|
|
202
East-West Bancorp
EWBC
$17.1B
| $64.5M | 0.1% |
2,018,232
+99,726
| +5% | +$3.02M |
2013 Q2
1 quarter
|
|
|
ARUN
203
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $64.4M | 0.1% |
3,869,778
+1,364,361
| +54% | +$23.8M |
2013 Q2
1 quarter
|
|
204
AMC Global Media
AMCX
$463M
| $64.1M | 0.1% |
936,319
+209,644
| +29% | +$13.9M |
2013 Q2
1 quarter
|
|
205
Berkshire Hathaway Class B
BRK.B
$1.07T
| $63.9M | 0.1% |
562,996
+26,214
| +5% | +$3.02M |
2013 Q2
1 quarter
|
|
206
Designer Brands
DBI
$310M
| $63.8M | 0.1% |
1,495,590
+603,236
| +68% | +$24.4M |
2013 Q2
1 quarter
|
|
207
CALL
Herbalife
HLF
$1.29B
| $63.8M | 0.1% |
1,827,600
+1,457,400
| +394% | +$45.1M |
2013 Q2
1 quarter
|
|
208
DuPont de Nemours
DD
$17.4B
| $63.7M | 0.1% |
+655,078
| New | +$61M |
2013 Q3
0 quarters
|
|
|
YHOO
209
CALL
DELISTED
Yahoo Inc
YHOO
| $63.7M | 0.1% |
1,920,800
+834,900
| +77% | +$23.6M |
2013 Q2
1 quarter
|
|
|
FINL
210
DELISTED
Finish Line
FINL
| $63.6M | 0.1% |
2,557,940
+1,150,321
| +82% | +$25.5M |
2013 Q2
1 quarter
|
|
|
CXO
211
DELISTED
CONCHO RESOURCES INC.
CXO
| $63M | 0.1% |
579,114
+303,066
| +110% | +$28.9M |
2013 Q2
1 quarter
|
|
212
AB InBev
BUD
$144B
| $62.3M | 0.09% |
628,030
+594,394
| +1,767% | +$56.6M |
2013 Q2
1 quarter
|
|
|
BNY
213
Bank of New York Mellon
BNY
$97.7B
| $62.2M | 0.09% |
2,061,026
+1,677,507
| +437% | +$51.5M |
2013 Q2
1 quarter
|
|
214
PUT
Intuitive Surgical
ISRG
$142B
| $61.7M | 0.09% |
1,475,100
+347,400
| +31% | +$15.3M |
2013 Q2
1 quarter
|
|
|
RATE
215
DELISTED
Bankrate Inc
RATE
| $61.2M | 0.09% |
2,976,523
-1,159,424
| -28% | -$19.9M |
2013 Q2
1 quarter
|
|
216
PUT
Chevron
CVX
$406B
| $61.2M | 0.09% |
503,800
+222,300
| +79% | +$27.3M |
2013 Q2
1 quarter
|
|
217
PUT
Regeneron Pharmaceuticals
REGN
$75.7B
| $61.1M | 0.09% |
195,400
+54,900
| +39% | +$14.4M |
2013 Q2
1 quarter
|
|
|
218
PUT
Visa
V
$676B
| $60.8M | 0.09% |
1,273,600
+501,600
| +65% | +$23.2M |
2013 Q2
1 quarter
|
|
219
Capital One
COF
$119B
| $60.8M | 0.09% |
884,986
+285,998
| +48% | +$19.2M |
2013 Q2
1 quarter
|
|
|
FNSR
220
DELISTED
Finisar Corp
FNSR
| $60.6M | 0.09% |
+2,678,698
| New | +$55.2M |
2013 Q3
0 quarters
|
|
|
AWH
221
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $60.5M | 0.09% |
1,827,150
-1,049,349
| -36% | -$33M |
2013 Q2
1 quarter
|
|
222
Devon Energy
DVN
$51.9B
| $60.5M | 0.09% |
1,047,786
+805,402
| +332% | +$46M |
2013 Q2
1 quarter
|
|
223
CALL
Procter & Gamble
PG
$334B
| $60.5M | 0.09% |
800,400
+325,800
| +69% | +$25.9M |
2013 Q2
1 quarter
|
|
224
NOV
NOV
$6.74B
| $60.5M | 0.09% |
858,975
+100,178
| +13% | +$6.7M |
2013 Q2
1 quarter
|
|
225
PUT
Johnson & Johnson
JNJ
$623B
| $60.4M | 0.09% |
697,300
+169,400
| +32% | +$15.2M |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.